Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats. - Test2 - elhamkhani - TriplyDB

Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats.

Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats.

http://www.wikidata.org/entity/Q36802929

about

Echocardiographic integrated backscatter for detecting progression and regression of aortic valve calcifications in rats.Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner Animal models of calcific aortic valve disease Aortic valve calcification in mild primary hyperparathyroidism.Cellular Changes during Renal Failure-Induced Inflammatory Aortic Valve Disease.Dietary phosphate restriction ameliorates endothelial dysfunction in adenine-induced kidney disease rats.Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure.Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive?Histopathology and apoptosis in an animal model of reversible renal injury.Serum phosphate concentrations: a novel pre-clinical biomarker for cardiovascular calcification.Persistence of Vascular Calcification after Reversal of Uremia.Interaction of renal failure and dyslipidaemia in the development of calcific aortic valve disease in rats.Klotho suppresses high phosphate-induced osteogenic responses in human aortic valve interstitial cells through inhibition of Sox9.

P2860

Q30456255-BC5724B4-6412-4733-AC9D-FE169F3AFB96 Q33589249-575FBFFF-AEA5-430F-B39A-8452E4E82B03 Q33939707-DAB16B53-5897-4139-89A1-BC00F5BE3929 Q35147157-2BA9B26E-0EE6-4581-A893-842C9252D0EA Q35654167-26F1EEE4-1338-4C9F-B841-FE8C73F8E873 Q35662347-B41B5055-7937-4ABF-A6B6-12216F38D778 Q36082389-606D2E54-C2F4-4856-9115-2CC963AEED3B Q36943228-2EC90797-33E0-42FD-829E-2A03B3105F21 Q37174180-BFFE3E75-8A3A-4717-8732-4C8109D6652C Q37591706-645736BA-53C5-4FD8-A8D1-52845633B94E Q37633971-849BEBC9-BC2B-48CA-9E78-80148CB682F9 Q42412476-E81DC895-C3A4-4F7B-AD37-BAFA7B025E4C Q48016566-2CA1687C-7CDE-4A8A-84FF-703DCB87D85A Q48210399-4E15BEFD-10B3-4ED5-9AD9-DCB314E54641 Q51090192-F150FD26-7E0B-40B8-965F-DC3A49527E65

P2860

Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats.

http://www.wikidata.org/entity/Q36802929

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Uraemic hyperparathyroidism ca ...... c valve calcification in rats.

@ast

Uraemic hyperparathyroidism ca ...... c valve calcification in rats.

@en

type

label

Uraemic hyperparathyroidism ca ...... c valve calcification in rats.

@ast

Uraemic hyperparathyroidism ca ...... c valve calcification in rats.

@en

prefLabel

Uraemic hyperparathyroidism ca ...... c valve calcification in rats.

@ast

Uraemic hyperparathyroidism ca ...... c valve calcification in rats.

@en

P1433

Q36802929-692DE271-A4A5-4C69-B4A8-BE54A6C40CC9

P1476

Q36802929-32BB9D0C-DFE0-4506-B59E-3D64097C21FB

P2093

Q36802929-14D7C7B7-A47E-4A16-AEE8-BCFE64895F86

Q36802929-2E8691F1-ABE8-48FD-B8F7-9EC19E127D65

Q36802929-3BC1EEF1-B07F-42D5-99FB-72FB93D30771

Q36802929-6D4DF609-564D-4F76-A52C-BB5C5C5DCF27

Q36802929-84755385-FE24-4DA8-B892-DEBE93B0FDB0

Q36802929-A63533C7-44D1-4F5D-AF6A-FB59EC1ECF27

Q36802929-C23468D7-A66A-4C73-B42B-D68AE640E07D

Q36802929-E556602D-C62B-44D4-AA61-BD1A6B03E7F7

Q36802929-EFF69ABC-5C7B-44F2-A96B-140D43FC4107

P2860

Q36802929-03AE41A0-9AC0-4585-A76E-C968A9006859

Q36802929-0BF5DADF-77DF-4E5D-90C5-F9205B87CDC2

Q36802929-106D3053-84C3-4502-830A-5510AC4DBED8

Q36802929-147ADD45-082B-4F25-A2BF-F7C5D62596D5

Q36802929-1B77596B-B540-4419-8C10-BFA43B84BB42

Q36802929-1D5DACF4-56E1-4B78-863F-0F6855B625D2

Q36802929-24FDD2F4-AE9C-41A2-847F-E29CEACF2D1F

Q36802929-31269B4A-B65E-48BF-B7E0-7ADC5AB1DD99

Q36802929-34930427-4933-4109-82CA-2BB12955897F

Q36802929-361541FD-80FD-4BA5-A10E-7EFDAAA56576

P304

Q36802929-ED969EDB-1098-4FF7-83CF-D82631D2E20F

P31

Q36802929-5A585665-3D5E-41C9-8FBE-565240A3ECD9

P356

Q36802929-8108037E-5D82-432C-BCF5-2B665681BE5C

P433

Q36802929-6149EFE1-C416-4B18-9F0E-5FB05D52DC75

P478

Q36802929-251277B4-C0ED-4116-A68D-BE5C708E0305

P577

Q36802929-BB19CBD9-F22F-4787-A189-5BBA7E0F6D3B

P5875

Q36802929-510461E7-9371-494B-8E15-CBF9D48538DA

P698

Q36802929-887E9EBC-D9D7-4ED8-ABCA-67212EFFB914

P921

Q36802929-B307B586-585E-4780-8297-1F7B54AFDB66

Q36802929-F8E4D740-A72E-4C0C-8FE6-2D20F9B3F356

P932

Q36802929-0A06ABE7-6FCD-4FA3-88C7-EE0F45F10727

P356

P1433

Cardiovascular Research

P1476

Uraemic hyperparathyroidism ca ...... c valve calcification in rats.

@en

P2093

Chaim Lotan

http://www.w3.org/2001/XMLSchema#string

David Planer

http://www.w3.org/2001/XMLSchema#string

Haim D Danenberg

http://www.w3.org/2001/XMLSchema#string

Iddo Z Ben-Dov

http://www.w3.org/2001/XMLSchema#string

Jacob Sosna

http://www.w3.org/2001/XMLSchema#string

Karen Meir

http://www.w3.org/2001/XMLSchema#string

Mony Shuvy

http://www.w3.org/2001/XMLSchema#string

Ronen Beeri

http://www.w3.org/2001/XMLSchema#string

Suzan Abedat

http://www.w3.org/2001/XMLSchema#string

P2860

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis

The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis

Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.

Vitamin D: its role and uses in immunology.

Runx2/Cbfa1: a multifunctional regulator of bone formation.

Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.

Epidemiology and cardiovascular risk factors of aortic stenosis.

Influence of the parathyroid glands on bone metabolism.

Novel insights into vascular calcification.

P304

492-499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVN088

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5461457

http://www.w3.org/2001/XMLSchema#string

P698

18390899

http://www.w3.org/2001/XMLSchema#string

P921

hyperparathyroidism

P932

2492726

http://www.w3.org/2001/XMLSchema#string